Abstract
A new and accurate chiral liquid chromatographic method has been developed for determination of the enantiomeric purity of montelukast sodium (R enantiomer) in bulk drugs and dosage forms. Normal phase chromatographic separation was performed on an immobilized amylose-based chiral stationary phase with n-hexane–ethanol–1,4-dioxane–trifluoroacetic acid–diethylamine 65:25:10:0.3:0.05 (v/v) as mobile phase at a flow rate of 1.0 mL min−1. The elution time was approximately 15 min. The resolution (R S) between the enantiomers was >3. The mobile phase additives trifluoroacetic acid and diethylamine played a key role in achieving chromatographic resolution between the enantiomers and also in enhancing chromatographic efficiency. Limits of detection and quantification for the S enantiomer were 0.07 and 0.2 μg, respectively, for a test concentration of montelukast sodium of 1,000 μg mL−1 and 10 μL injection volume. The linearity of the method for the S enantiomer was excellent (R 2 > 0.999) over the range from the LOQ to 0.3%. Recovery of the S enantiomer from bulk drug samples and dosage forms ranged from 97.0 to 103.0%, indicative of the high accuracy of the method. Robustness studies were also conducted. The sample solution stability of montelukast sodium was determined and the compound was found to be stable for a study period of 48 h.
Similar content being viewed by others
References
Labelle M, Belley M, Gareau Y, Gauthier JY, Guay D, Gordon R, Grossman SG, Jones TR, Leblanc Y, McAuliffe M, MaFarlane CS, Masson P, Metters KM, Ouimet N, Patrick DH, Piechuta H, Rochette C, Sawyer N, Xiang YB, Pickett CB, Ford-Hutchinson AW, Zamboni RJ, Young RN (1995) Bioorg Med Chem Lett 5:283–288. doi:10.1016/0960-894X(95)00023-M
Jones TR, Labelle M, Belly M, Champion E, Charette L, Evans J et al (1995) Can J Physiol Pharmacol 73:191–201
Gomes PJ, Abelson MB (2007) J Allergy Clin Immunol 119:S60. doi:10.1016/j.jaci.2006.11.258
Sterett S, Morton J, Perry D, Donovan J (2006) Urology 67:423e19–423e21
Ariens EJ, Wuns EW (1987) Clin Pharmacol Ther 42:361–363
Halabi A, Ferrayoli C, Palacio M, Dabbene V, Palacios S (2004) J Pharm Biomed Anal 34:45–51. doi:10.1016/j.japna.2003.08.020
Ochiai H, Uchiyama N, Takano T, Hara K-I, Kamei T (1998) J Chromatogr B Analyt Technol Biomed Life Sci 713:409–414. doi:10.1016/S0378-4347(98)00179-0
Al-Rawithi S, Al-Gazlan S, Al-Ahmadi W, Alshowaier IA, Yusuf A, Raines DA (2001) J Chromatogr B Analyt Technol Biomed Life Sci 754:527–531. doi:10.1016/S0378-4347(01)00025-1
Liu L, Cheng H, Zhao JJ, Rogers JD (2005) J Pharm Biomed Anal 15:631–638. doi:10.1016/S0731-7085(96)01894-8
Zhang T, Kientzy C, Franco P, Ohnishi A, Kagamihara Y, Kurosawa H (2005) J Chromatogr A 1075:65–75. doi:10.1016/j.chroma.2005.03.116
International conference on harmonisation (1995) ICH draft guidelines on validation of analytical procedures. Definitions and terminology. Federal Register, vol 60 IFPMA, Switzerland, p 11260
United States Pharmacopeia (2007) Validation of compendial methods. The United States Pharmacopeia, 30th edn. USP30
International Conference on Harmonisation (2003) Stability testing of new drug substances and products Q1A (R2). In: International conference on harmonization, IFPMA, Geneva
Acknowledgments
The authors wish to thank the management of United States Pharmacopeia-India (P) Ltd for supporting this work. The authors wish to acknowledge their colleagues in the Reference Standard Laboratory for their co-operation in performing this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Radhakrishnanand, P., Subba Rao, D.V., Surendranath, K.V. et al. A Validated LC Method for Determination of the Enantiomeric Purity of Montelukast Sodium in Bulk Drug Samples and Pharmaceutical Dosage Forms. Chroma 68, 263–267 (2008). https://doi.org/10.1365/s10337-008-0684-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-008-0684-5